Breaking Barriers: How DanGer Shock RCT Helps Advance AMI-Cardiogenic Shock Treatment
By
Abiomed
FEATURING
Babar Basir
By
Abiomed
FEATURING
Babar Basir
Join Dr. Babar Basir, Henry Ford Medical Center and Abiomed VP of Professional Education Dr. Seth Bilazarian for an interview discussing the results of the DanGer Shock RCT published in the NEJM. The discussion includes how the study removes the barriers in understanding how to treat patients in AMI-Cardiogenic Shock and how the results help with shock staging and align with the National Cardiogenic Shock Initiative.
Comments 0
Login to view comments.
Click here to Login
